Gastrodin Ameliorates Pain-Depression Comorbidity through SIRT3-Dependent Alleviation of Oxidative Stress and Promotion of Mitochondrial Biogenesis

Key Points

• Gastrodin treatment significantly reduces pain-depression comorbidity, enhancing overall well-being.
• Using a model of comorbidity, researchers observed a marked decrease in oxidative stress levels following treatment.
• The study employed an observational design to track mitochondrial biogenesis improvements related to SIRT3 functions.
• Findings suggest potential new therapeutic directions for addressing chronic pain and associated depression.